3
Clinical Trials associated with [18F]Fluortriopride / Active, not recruitingPhase 1/2IIT Evaluation of D3 Receptor Occupancy Using [18F]FLUORTRIOPRIDE ([18F]FTP) PET/CT
Preclinical work suggests that D3 dopamine receptors may be important in the study of the pathophysiology of affective disorders, psychotic disorders and addiction. D3 receptors may also play a role in dystonia, Parkinson's disease and response to treatment of these disorders. However, there has been a lack of specific radioligands for imaging D3 receptors. This proposed protocol will evaluate the uptake of [18F]FTP as a more specific in vivo measure of D3 receptor binding in the brain in healthy volunteers subjects after injection of lorazepam vs placebo, and in cocaine-dependent subjects. Test-retest scans will evaluate the variability of [18F]FTP uptake measures in both healthy volunteer subjects and cocaine-dependent subjects.
/ Active, not recruitingPhase 1IIT Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT
In this phase 1 pilot study, positron emission tomography (PET/CT) imaging will be used to determine the biodistribution, metabolism and excretion of a novel radiotracer [18F]Fluortriopride ([18F]FTP).
/ CompletedNot ApplicableIIT A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism
Studies of myocardial fuel selection using a novel palmitate-based PET probe
100 Clinical Results associated with [18F]Fluortriopride
100 Translational Medicine associated with [18F]Fluortriopride
100 Patents (Medical) associated with [18F]Fluortriopride
100 Deals associated with [18F]Fluortriopride